Autism researcher Joseph Buxbaum describes the SHANK3 gene and the promise of IGF1

Dr. Joseph Buxbaum is the Director of the Seaver Autism Center. Dr. Buxbaum discusses the SHANK3 gene, which helps synapses to properly function. Around 1% of children with ASD have SHANK3 mutations, making it one of the most common single-gene causes of autism. Dr. Buxbaum also discusses Insulin-like Growth Factor (IGF1), which is the second drug aimed at treating core symptoms of autism, and is currently being tested on humans.